| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |